24 Feb Date February 24, 2021 Categories News Phase 3 human clinical trial shows that metabolic activators accelerates recovery in COVID-19 patients The Swedish biotechnology company ScandiBio Therapeutics today announced results from the study “Combined Metabolic Activators A...
04 Feb Date February 4, 2021 Categories News Phase 2 human clinical trial shows that metabolic activators reduces liver fat in NAFLD patients ScandiBio Therapeutics announced results from the study “Combined Metabolic Activators Reduces Liver Fat in Nonalcoholic Fatty L...